Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Pelitinib |
| Synonyms | |
| Therapy Description |
Pelitinib (EKB-569) is a nonselective inhibitor of EGFR, ERBB2 (HER2), and ERBB4 (HER4), which induces apoptosis and inhibits cell proliferation (PMID: 25988710). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Pelitinib | EKB-569|WAY-EKB 569 | EGFR Inhibitor (Pan) 63 HER2 Inhibitor 44 | Pelitinib (EKB-569) is a nonselective inhibitor of EGFR, ERBB2 (HER2), and ERBB4 (HER4), which induces apoptosis and inhibits cell proliferation (PMID: 25988710). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|